Switch to:

Denali Therapeutics EV-to-EBIT

: -15.23 (As of Today)
View and export this data going back to 2017. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Denali Therapeutics's Enterprise Value is $1,043.4 Mil. Denali Therapeutics's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was $-68.5 Mil. Therefore, Denali Therapeutics's EV-to-EBIT for today is -15.23.

NAS:DNLI' s EV-to-EBIT Range Over the Past 10 Years
Min: -35.4   Max: -6.2
Current: -15.23

-35.4
-6.2

During the past 4 years, the highest EV-to-EBIT of Denali Therapeutics was -6.20. The lowest was -35.40. And the median was -18.80.

NAS:DNLI's EV-to-EBIT is ranked lower than
99.99% of the 265 Companies
in the Biotechnology industry.

( Industry Median: 16.30 vs. NAS:DNLI: -15.23 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Denali Therapeutics's Enterprise Value for the quarter that ended in Jun. 2019 was $1,574.8 Mil. Denali Therapeutics's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was $-68.5 Mil. Denali Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2019 was -4.35%.


Denali Therapeutics EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
EV-to-EBIT 0.00 0.00 -10.67 -32.01

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.15 -11.53 -32.01 -28.38 -22.99

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Denali Therapeutics EV-to-EBIT Distribution

* The bar in red indicates where Denali Therapeutics's EV-to-EBIT falls into.



Denali Therapeutics EV-to-EBIT Calculation

Denali Therapeutics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1043.358/-68.513
=-15.23

Denali Therapeutics's current Enterprise Value is $1,043.4 Mil.
Denali Therapeutics's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was -37.964 (Sep. 2018 ) + 74.722 (Dec. 2018 ) + -42.508 (Mar. 2019 ) + -62.763 (Jun. 2019 ) = $-68.5 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics  (NAS:DNLI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Denali Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2019 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2019 =EBIT / Enterprise Value (Q: Jun. 2019 )
=-68.513/1574.7842
=-4.35 %

Denali Therapeutics's Enterprise Value for the quarter that ended in >Jun. 2019 was $1,574.8 Mil.
Denali Therapeutics's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was -37.964 (Sep. 2018 ) + 74.722 (Dec. 2018 ) + -42.508 (Mar. 2019 ) + -62.763 (Jun. 2019 ) = $-68.5 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics EV-to-EBIT Related Terms


Denali Therapeutics EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)